• About
    ▼
    • Overview
    • Leadership
    • Our Team
    • Board of Directors
    • Investors
  • Science
    ▼
    • Overview
    • Highly Cytotoxic T Cells
    • KLRG1
    • Posters & Presentations
  • Pipeline
    ▼
    • Overview
    • ABC008
    • IBM
    • T-LGLL
    • Additional Indications
    • ABC015
  • News
  • Careers
  • Contact
Investors

Investors

About

Abcuro

Breakthrough Therapies for Autoimmune Diseases & Cancer

  • About
    • Overview
    • Leadership
    • Our Team
    • Board of Directors
    • Investors
  • Science
    • Overview
    • Highly Cytotoxic T Cells
    • KLRG1
    • Posters & Presentations
  • Pipeline
    • Overview
    • ABC008
    • IBM
    • T-LGLL
    • Additional Indications
    • ABC015
  • News
  • Careers
  • Contact

Investors

Hongsen Investment

September 17, 2021

Mass General Brigham Ventures

September 17, 2021

Pontifax

September 17, 2021

RA Capital

September 17, 2021

Samsara Biocapital

September 17, 2021

Sanofi Ventures

September 17, 2021

Privacy Site Credits Terms of Use

© 2022 Abcuro